The first patient has been dosed in a Phase 1/2 clinical study of VTx-002, an experimental therapy for amyotrophic lateral sclerosis.

Experts have highlighted the potential of irpagratinib to become the first truly precision-targeted therapy for liver cancer. With FDA fast track designation now in place, Abbisko Therapeutics plans ...

Virtual Webinar on Tuesday, Feb. 17 at 3 p.m. ET / 12 p.m. PT─ Will feature discussion and insights from Fred Grossman, D.O., FAPA; Stanley Appel, M.D.; and James Berry, M.D., MPH — accomplished ...

With medically integrated dispensing (MID) models, pharmacists are more embedded in care and engage more frequently with patients, according to Kenneth Komorny, PharmD, BCPS, of Moffitt Cancer Center.

The disputes stem from rising health care costs, with insurers and hospitals fighting more aggressively over the price of ...

Lawmakers are once again debating how to reform New Mexico’s medical malpractice laws this session, reigniting a long-running ...

Medical-grade body composition analysis, InBody 770 reporting, and physician review—plus optional advanced metabolic ...

The Bradenton behavioral health center paid nearly $700,000 to an unlicensed "group home" owner and a Miami Beach Realtor to ...

People with dementia are legally entitled to have a say in their treatment but are rarely included when it comes to their care planning, according to a review of research. There are around 1 million ...

Powered by conversational AI, the tool aims to plug Hong Kong's palliative care workforce gap – with fewer than one specialist per 100,000 people – as advance medical directive legislation takes ...

Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a ...

The University of Minnesota is cementing its role as a leading national voice on vaccine safety and effectiveness, announcing a partnership Tuesday with the American Medical Association (AMA) to give ...